News Image

Discover the top movers in Wednesday's pre-market session and stay informed about market dynamics.

By Mill Chart

Last update: May 8, 2024

The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.

Today's pre-market gainers

TickerChangeComment
ISUN61.29%ISUN INC's (NASDAQ:ISUN) shares rose 61.29% to $0.21 during Wednesday's pre-market session. In the last month the stock lost 45.23%.
SLNH44.03%During Wednesday's pre-market session, SOLUNA HOLDINGS INC (NASDAQ:SLNH) experienced a 44.03% increase, with the stock price reaching $3.5. A press release (Soluna Launches New AI Cloud Service in Collaboration with Leading High Performance Computing Company) was released earlier today.
INOD21.96%INNODATA INC's (NASDAQ:INOD) shares rose 21.96% to $8.22. A press release (INNODATA ALERT: Bragar Eagel & Squire, P.C. is Investigating Innodata Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm) was released two days ago.
RPTX19.82%REPARE THERAPEUTICS INC (NASDAQ:RPTX) rose 19.82% to $3.93 during Wednesday's pre-market session. REPARE THERAPEUTICS INC released earnings Yesterday. A press release (Repare Therapeutics Provides Business and Clinical Update and Reports First Quarter 2024 Financial Results) was released yesterday.
CLOV18.76%During Wednesday's pre-market session, CLOVER HEALTH INVESTMENTS CO (NASDAQ:CLOV) experienced a 18.76% increase, with the stock price reaching $0.88. In the last 3 months the share price dropped with 27.45%.
MYGN18.3%MYRIAD GENETICS INC (NASDAQ:MYGN) recorded a 18.3% increase in share price during the pre-market session, reaching $23.4 on Wednesday. Yesterday the company had a press release: Myriad Genetics Reports Strong First Quarter 2024 Financial Results; Achieves 12% Revenue Growth Year-Over-Year; Significantly Improved Year-Over-Year Net Loss and Generated Positive Adjusted EBITDA.
SGD17.32%SAFE & GREEN DEVELOPMENT COR's (NASDAQ:SGD) stock price increased by 17.32% to $0.46. Following a -21.97% loss in the previous session, NASDAQ:SGD displays significant price volatility in today's pre-market session. A press release (Safe and Green Development Corporation to Acquire MyVonia, a Cutting-Edge AI Asset) was released yesterday.
ENVB15.73%During Wednesday's pre-market session, ENVERIC BIOSCIENCES INC (NASDAQ:ENVB) experienced a 15.73% increase, with the stock price reaching $1.03. A press release (Enveric Biosciences Announces Signing of Non-Binding Term Sheet with Undisclosed Licensee for Exclusive License to Patented Methods of Treating Breast and Other Cancers Using Cannabinoids) was released earlier today.
OPFI14.44%Investors witnessed a remarkable surge in OPPFI INC (NYSE:OPFI) during Wednesday's pre-market session, with the stock price rising 14.44% to $3.09. yesterday the company released their earnings. A press release (OppFi Exceeds First Quarter 2024 Guidance, Raises Full-Year Earnings Outlook) was released earlier today.
COCH13.89%ENVOY MEDICAL INC's (NASDAQ:COCH) shares rose 13.89% to $3.28 during Wednesday's pre-market session. Despite a -16.28% decrease just yesterday, there is a notable recovery in today's pre-market session for NASDAQ:COCH.

For the full premarket gainers list go to our premarket gainers page.

Today's pre-market losers

TickerChangeComment
TMCI-57.82%TREACE MEDICAL CONCEPTS INC's (NASDAQ:TMCI) shares experienced a 57.82% decline, falling to $4.69 during Wednesday's pre-market session. The stock is trading 27.84% lower than 3 months ago.
DV-39.94%DOUBLEVERIFY HOLDINGS INC's (NYSE:DV) shares fell 39.94% to $18.36. Yesterday the company had a press release: DoubleVerify Reports First Quarter 2024 Financial Results.
ZI-21.16%Wednesday's pre-market session showed a 21.16% decrease in the stock price of ZOOMINFO TECHNOLOGIES INC (NASDAQ:ZI), reaching $12.63. A press release (ZoomInfo Announces First Quarter 2024 Financial Results) was released yesterday.
INSP-20.63%INSPIRE MEDICAL SYSTEMS INC's (NYSE:INSP) shares fell 20.63% to $194.95. In the last 3 months the stock gained 26.05%.
SHOP-18.36%SHOPIFY INC - CLASS A's (NYSE:SHOP) stock price decreased by 18.36% to $62.9. The company's earnings where released Yesterday. Shareholders saw the stock price going 25.61% higher is the past 6 months.
WD-17.13%The stock price of WALKER & DUNLOP INC (NYSE:WD) is experiencing a decline of 17.13%, reaching $80.0 in today's pre-market session on Wednesday. In the last 6 months the share price increased with 35.06%.
GRFX-16.44%Wednesday's pre-market session showed a 16.44% decrease in the stock price of GRAPHEX GROUP LTD-SPON ADR (NYSEARCA:GRFX), reaching $0.38. After a strong performance yesterday with a 50.0% gain, NYSEARCA:GRFX shows signs of retracement with a 16.44% decline in today's pre-market session.
GO-15.95%During Wednesday's pre-market session, the shares of GROCERY OUTLET HOLDING CORP (NASDAQ:GO) declined by 15.95%, reaching $21.77. Yesterday the company had a press release: Grocery Outlet Holding Corp. Announces First Quarter Fiscal 2024 Financial Results.
AMRK-15.72%The pre-market session on Wednesday witnessed a 15.72% decrease in A-MARK PRECIOUS METALS INC's (NASDAQ:AMRK) shares, with the stock price falling to $34.0. The stock is trading 52.4% higher than 3 months ago.
TRIP-15.62%The stock price of TRIPADVISOR INC (NASDAQ:TRIP) is experiencing a decline of 15.62%, reaching $21.5 in today's pre-market session on Wednesday. In the last 6 months the stock gained 46.69%.

For the full premarket loser list go to our premarket losers page.

Back

MYRIAD GENETICS INC

NASDAQ:MYGN (5/17/2024, 7:15:24 PM)

After market: 25.29 0 (0%)

25.29

+0.68 (+2.76%)

MYGN News

News Image3 days ago - Myriad Genetics, Inc.New Study Published in JCO Precision Oncology Shows Myriad Genetics' Prolaris Test Can Predict Benefit of Hormone Therapy Treatment in Men with Localized Prostate Cancer
News Image3 days ago - Myriad Genetics, Inc.New Study Published in JCO Precision Oncology Shows Myriad Genetics' Prolaris Test Can Predict Benefit of Hormone Therapy Treatment in Men with Localized Prostate Cancer

Myriad’s Prolaris Test is the only biomarker test to quantify the benefits of adding androgen deprivation therapy to radiation therapy1 SALT LAKE CITY,...

News Image10 days ago - InvestorPlaceGenomics Game-Changers: 3 Stocks Unlocking the Secrets of Life

Genomics is the future of medicine, creating big opportunity for some of the top genomics stock picks to buy today.

News Image11 days ago - ChartmillDiscover the top movers in Wednesday's pre-market session and stay informed about market dynamics.

The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.

News Image12 days ago - InvestorPlaceMYGN Stock Earnings: Myriad Genetics Beats EPS, Beats Revenue for Q1 2024

MYGN stock results show that Myriad Genetics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

News Image12 days ago - BusinessInsiderMYGN Stock Earnings: Myriad Genetics Beats EPS, Beats Revenue for Q1 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Myriad Genetics (NASDAQ:MYGN) just reported results for the first quarter of 20...

News Image12 days ago - Myriad Genetics, Inc.Myriad Genetics Reports Strong First Quarter 2024 Financial Results; Achieves 12% Revenue Growth Year-Over-Year; Significantly Improved Year-Over-Year Net Loss and Generated Positive Adjusted EBITDA
News Image12 days ago - Myriad Genetics, Inc.Myriad Genetics Announces Reorganization of European Operations and Sale of EndoPredict Business
News Image12 days ago - Myriad Genetics, Inc.Myriad Genetics Announces Reorganization of European Operations and Sale of EndoPredict Business

SALT LAKE CITY, May 07, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today...

News Image19 days ago - Myriad Genetics, Inc.Myriad Genetics to Release First Quarter 2024 Financial Results on May 7, 2024

Management will also participate in four upcoming investor healthcare conferences

News Image19 days ago - Myriad Genetics, Inc.Myriad Genetics to Release First Quarter 2024 Financial Results on May 7, 2024

Management will also participate in four upcoming investor healthcare conferences...

News Imagea month ago - Myriad Genetics, Inc.Nearly Half of Americans Say They’ve Lost Time in Their Lives Due to Poor Mental Health, According to the GeneSight Mental Health Monitor

80% of people diagnosed with anxiety, depression report losing years or decades of time

MYGN Links
Follow us for more